MDT News and Press, Medtronic plc. From 03/28/24

2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...

2024-03-28 09:44:31 ET Summary Insulet Corporation, the maker of the Omnipod Insulin Management System, provides essential services to a patient group of 10 million diabetes patients and has experienced significant growth over the past decade. The company's wearable and discrete s...

Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy (also known as BackBeat Cardiac Neuromodulation Therapy) in hypertensive pacemaker patients in collaboration with Medtronic, plc (NYSE: MDT) in December 2023 Orchestra BioMed and Terumo remain actively engag...

2024-03-27 10:24:23 ET More on Medtronic Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript) Medtronic: Undervalued Medical Devices Stock With Robust ...

2024-03-27 09:00:47 ET Palm Beach, FL – March 27, 2024 – FN Media Group News Commentary – Artificial intelligence (AI) in the healthcare market is highly competitive due to a significant number of players operating in the domestic and international markets. ...

2024-03-27 08:00:00 ET Summary Medtronic has upped its dividend for 46 consecutive years. The MedTech company topped analysts' expectations in the fiscal third quarter for revenue and non-GAAP EPS. Medtronic's financial health is vibrant enough to possess an A rating from S&am...

Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis Canada NewsWire The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary acc...

2024-03-26 09:29:13 ET More on Tandem Diabetes Care Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript Tandem Diabetes Care GAAP EPS of -$0.46 misses by $0.19, revenue of $196.8M misses by $6.05M Seeking Alpha’s Quant Rating on Tandem Diabetes ...

2024-03-21 15:39:25 ET More on Medtronic, Axonics Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth Medtronic: Its Recent Beat Proves That It Continues To Be A Rock Boston Scientific pulls, refiles HSR notification for Axonics...

U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents Canada NewsWire Medtronic moves for patent infringement litigation to resume DUBLIN , March 21 , 2024 /CNW/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today an...